JESSICA WERESNICK: Open Payments
NPI 1114497807 · MOREHEAD CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 26 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $381 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Amgen Inc. | 3 | $43 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, Wegovy, OTEZLA, Rybelsus, BREZTRI, FANAPT, HETLIOZ, FARXIGA.
Industry payments across NC — which companies pay providers there.
